Sorry, I can't remember where I read or heard the ML was anticipated by around the end of trial mining but it was public. Perhaps someone else remembers.
"You may be right in that they may choose to go straight to stage 3 once they have some significant funds from stage 2.
I cannot see any info confirming this either way. Do you have info that shows stage 3 commencing well before stage 2 completion?"
No but that was my point. There is no plan on timing of stage 3. They will move to stage 3 when they collect enough info to let them know what might be the optimal size of stage 3.
I see no reason why that would take more than 1 year -if that.
"Bit confused here as I didn't mention any cash flow estimates in relation to stage 3."
I realise that but you assumed stage 2 continues for 3 years and I was just pointing out my assumption is an earlier move to stage 3 therefore giving different cash flow estimate.
- Forums
- ASX - By Stock
- PRX
- posing a few questions re. abm
PRX
prodigy gold nl
Add to My Watchlist
33.3%
!
0.2¢

posing a few questions re. abm, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.350M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $4.72K | 2.259M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 20577442 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 77460764 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 20577442 | 0.002 |
52 | 215171310 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 77460764 | 36 |
0.004 | 12798333 | 8 |
0.005 | 1935720 | 3 |
0.006 | 50000 | 1 |
0.008 | 3926371 | 1 |
Last trade - 15.32pm 04/07/2025 (20 minute delay) ? |
Featured News
PRX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online